Exploring your options for Chronic Leukemia in India? Ginger Healthcare brings together a carefully chosen panel of reputed hematologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Chronic Leukemia Treatment. Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Here are the most reputed hospitals in India for Chronic Leukemia Treatment. These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Chronic leukemia is a family of slow-progressing blood cancers in which the bone marrow produces abnormal white blood cells that gradually crowd out healthy cells. The two most common types are chronic myeloid leukemia (CML), driven by the BCR-ABL1 genetic change, and chronic lymphocytic leukemia (CLL), in which abnormal B lymphocytes accumulate over time. Unlike acute leukemias, chronic leukemias often develop over months to years and may cause few or no symptoms early on. Treatment has been transformed by targeted oral therapies — tyrosine kinase inhibitors for CML and BTK or BCL-2 inhibitors for CLL — meaning most patients today can expect good disease control and near-normal daily life. For early-stage CLL without symptoms, active monitoring without medication is often the appropriate first step, while advanced or high-risk disease may require chemotherapy, immunotherapy, or stem cell transplantation.
Regular blood tests and clinic reviews without any medication — the recommended first step for asymptomatic early-stage CLL, where starting treatment immediately has not been shown to improve outcomes.
Estimated cost: ~$1,000 – $1,500
Typical tests: Complete blood count (CBC) with differential, Peripheral blood smear, Flow cytometry (immunophenotyping), FISH panel — del(17p), del(11q), trisomy 12, del(13q), IGHV mutation status (for CLL), CT scan — chest, abdomen, and pelvis, LFT, KFT, uric acid, LDH, Bone marrow aspiration and biopsy (if clinically indicated). Done in India before admission.
Estimated cost in India: $3,000 – $5,000
Treatment duration in India: ~2 weeks (~5 hospital visit days across the full span)
Daily oral targeted medicines that block the specific proteins driving leukemia cell growth — tyrosine kinase inhibitors for CML, or BTK / BCL-2 inhibitors for CLL — taken long-term with regular monitoring.
Estimated cost: ~$1,000 – $1,500
Typical tests: Complete blood count (CBC) with differential, BCR-ABL1 quantitative PCR (for CML) or IGHV / TP53 panel (for CLL), FISH cytogenetics panel, Flow cytometry (immunophenotyping), LFT, KFT, uric acid, LDH, electrolytes, ECG and cardiac assessment (required before certain TKIs and BTK inhibitors), CT scan — chest, abdomen, and pelvis, Bone marrow aspiration and biopsy. Done in India before admission.
Estimated cost in India: $4,000 – $10,000
Treatment duration in India: ~3 weeks (~7 hospital visit days across the full span)
Intravenous chemotherapy — sometimes combined with monoclonal antibodies such as rituximab — used when targeted therapy is unsuitable, for advanced-phase CML, or as preparation for a stem cell transplant.
Estimated cost: ~$1,000 – $1,500
Typical tests: Complete blood count (CBC) with differential, Bone marrow aspiration and biopsy, Flow cytometry, FISH cytogenetics panel, LFT, KFT, uric acid, LDH, coagulation profile (PT/INR, APTT), Hepatitis B and C serology (required before rituximab), CT scan — chest, abdomen, and pelvis, ECG and 2D echocardiography. Done in India before admission.
Estimated cost in India: $5,000 – $15,000
That works out to roughly $500 – $2,500 per cycle across 6 cycles, plus a one-time pre-treatment work-up of about ~$1,000 – $1,500 (done once). Per-cycle figures are approximate — the headline range above covers the full course.
Treatment duration in India: ~6 months (6 cycles × 28 days, ~30 hospital visit days)
An advanced immunotherapy where the patient's own immune cells are genetically engineered in a laboratory to recognise and attack leukemia cells, used for CLL that has not responded to multiple lines of treatment.
Estimated cost in India: $35,000 – $60,000
For more details, visit: CAR-T Cell Therapy →
A transplant using stem cells from a matched donor to replace the patient's diseased bone marrow — the one treatment with genuine curative potential, reserved for high-risk or treatment-resistant chronic leukemia in fit patients.
Estimated cost in India: $20,000 – $45,000
For more details, visit: Bone Marrow Transplant (BMT) →
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
